TS 33
ActiveSummary
TS 33 has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €11.6m and a net result of €2.4m. Equity is growing by ~30.3% per year across the filed fiscal years. Its solvency ranks better than 32% of 9436 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Overview
- Equity
- €11.6m
- Profit
- €2.4m
- Holdings
- 12
Why 59+ Lower-failure-rate sector+ Annual accounts: healthy financial profile+ Long track recordLatest accounts filed on timeShow the evidence
Checked score
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
This company filed its last 7 accounts on average 80 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
- Annual accounts filedfiscal year 2025 · abbreviated…
- Appointment: Mercken Bedrijfsrevisoren BV (statutory auditor)Auditor report · Declaration ·…
- Liquidity triplescurrent ratio 2.13
Financials
Fiscal year 2025Total assets €88.6mProfit €2.4mSolvency 13.1%Liquidity 2.13
Financials · fiscal year 2025, abbreviated schema
Trend over the years
Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 68, Real estate activities, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).
- 2021 Net result +961% on 2020. This fiscal year ran 15 months, the previous one 12. The accounts now follow the abbreviated schema, last year the micro schema.
Result and balance sheet
Key figures and ratios
Filed annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | €0.008m | €0.02m | €1.0m | €5.4m | €5.0m | ▼ 6.3% |
| Remuneration, social security and pensions62 | €0.008m | €0.008m | €0 | - | - | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €0.4m | €0.4m | €0.4m | €0.4m | €0.3m | ▼ 21.7% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4 | - | - | - | €0.3m | €0 | ▼ 100% |
| Provisions for liabilities and charges: additions (uses and reversals)635/8 | €0.1m | -€0.1m | €0 | - | - | - |
| Other operating charges640/8 | €0.5m | €0.5m | €0.3m | €2.1m | €0.3m | ▼ 85.2% |
| Non-recurring operating charges66A | €0.02m | €0.002m | €0.1m | €0.03m | €0 | ▼ 100% |
| Gross operating margin9900 | €1.2m | -€3.6m | €0.5m | €6.7m | €4.7m | ▼ 29.8% |
| Operating profit (loss)9901 | €0.2m | -€4.3m | -€0.3m | €3.9m | €4.1m | ▲ 4.3% |
| Financial income75/76B | €2.8m | €0.003m | €7.5m | €0.1m | €1.0m | ▲ 890% |
| Recurring financial income75 | €2.8m | €468 | €0.04m | €0.05m | €0.1m | ▲ 86.4% |
| Non-recurring financial income76B | - | €0.002m | €7.4m | €0.05m | €0.9m | ▲ 1,779% |
| Financial charges65/66B | €0.4m | €0.5m | €1.4m | €3.2m | €2.6m | ▼ 18.5% |
| Recurring financial charges65 | €0.4m | €0.5m | €1.1m | €2.7m | €2.6m | ▼ 3.5% |
| Non-recurring financial charges66B | - | - | €0.3m | €0.5m | €0 | ▼ 100% |
| Profit (loss) for the period before taxes9903 | €2.6m | -€4.8m | €5.8m | €0.8m | €2.5m | ▲ 209% |
| Transfer from deferred taxes780 | €0.02m | €0.01m | €0.4m | €0.01m | €0.01m | = |
| Income taxes67/77 | €0.7m | €0 | - | €0.08m | €0.07m | ▼ 13.8% |
| Profit (loss) for the period9904 | €2.0m | -€4.8m | €6.2m | €0.7m | €2.4m | ▲ 232% |
| Transfer from tax-exempt reserves789 | €0.05m | €0.5m | €0.2m | €0.4m | €0.02m | ▼ 93.5% |
| Profit (loss) for the period to be appropriated9905 | €2.0m | -€4.2m | €6.4m | €1.1m | €2.4m | ▲ 122% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €58.6m | €100.2m | €97.8m | €89.5m | €88.6m | ▼ 1.0% |
| Fixed assets21/28 | €34.6m | €69.4m | €72.0m | €71.0m | €55.4m | ▼ 22.0% |
| Intangible fixed assets21 | €0.08m | €0.07m | €0.05m | €0.03m | €0.02m | ▼ 49.9% |
| Tangible fixed assets22/27 | €6.4m | €11.2m | €13.1m | €9.6m | €9.8m | ▲ 1.7% |
| Land and buildings22 | €5.8m | €10.7m | €10.4m | €9.1m | €8.8m | ▼ 2.9% |
| Plant, machinery and equipment23 | €0.06m | €0.07m | €0.07m | €0.05m | €0.02m | ▼ 62.1% |
| Furniture and vehicles24 | €0.4m | €0.3m | €0.3m | €0.2m | €0.2m | ▼ 11.9% |
| Leasing and similar rights25 | - | - | €0.02m | €0.02m | €0.02m | ▼ 12.1% |
| Other tangible fixed assets26 | €0.08m | €0.07m | €0.07m | €0.1m | €0.6m | ▲ 385% |
| Assets under construction and advance payments27 | - | €0.02m | €2.3m | €0.1m | €0.2m | ▲ 25.1% |
| Financial fixed assets28 | €28.1m | €58.1m | €58.9m | €61.3m | €45.6m | ▼ 25.7% |
| Current assets29/58 | €24.0m | €30.8m | €25.8m | €18.5m | €33.2m | ▲ 79.8% |
| Amounts receivable after more than one year29 | €6.1m | €6.1m | €5.1m | €5.2m | €8.1m | ▲ 54.6% |
| Other amounts receivable291 | €6.1m | €6.1m | €5.1m | €5.2m | €8.1m | ▲ 54.6% |
| Stocks and contracts in progress3 | €4.3m | €0.02m | €0.03m | €6.7m | €7.3m | ▲ 9.0% |
| Stocks30/36 | €4.3m | €0.02m | €0.03m | €6.7m | €7.3m | ▲ 9.0% |
| Amounts receivable within one year40/41 | €6.9m | €14.2m | €18.4m | €4.9m | €2.5m | ▼ 49.0% |
| Trade receivables40 | €2.0m | €0.5m | €0.5m | €3.2m | €0.2m | ▼ 93.9% |
| Other amounts receivable41 | €5.0m | €13.7m | €17.9m | €1.7m | €2.3m | ▲ 35.2% |
| Current investments50/53 | - | - | - | - | €12.9m | - |
| Cash at bank and in hand54/58 | €6.7m | €10.5m | €2.2m | €1.5m | €2.3m | ▲ 48.6% |
| Deferred charges and accrued income490/1 | - | - | - | €0.1m | €0.2m | ▲ 45.4% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €58.6m | €100.2m | €97.8m | €89.5m | €88.6m | ▼ 1.0% |
| Equity10/15 | €5.3m | €0.5m | €6.7m | €7.2m | €11.6m | ▲ 61.2% |
| Contributions10/11 | €0.07m | €0.07m | €0.07m | €0.07m | €2.1m | ▲ 2,688% |
| Reserves13 | €3.1m | €3.1m | €2.9m | €2.7m | €2.7m | ▼ 0.9% |
| Non-distributable reserves130/1 | €0.007m | €0.007m | €0.007m | €0.007m | €0.007m | = |
| Reserves not available under the articles1311 | €0.007m | €0.007m | €0.007m | €0.007m | €0.007m | = |
| Tax-exempt reserves132 | €2.0m | €1.5m | €1.3m | €0.7m | €0.7m | ▼ 3.4% |
| Distributable reserves133 | €1.1m | €1.6m | €1.6m | €2.0m | €2.0m | = |
| Profit (loss) carried forward14 | €2.0m | -€2.7m | €3.7m | €4.5m | €6.9m | ▲ 54.7% |
| Provisions and deferred taxes16 | €0.6m | €0.5m | €0.06m | €0.3m | €0.3m | ▼ 3.7% |
| Provisions for liabilities and charges160/5 | €0.1m | €0 | - | - | - | - |
| Other liabilities and charges164/5 | €0.1m | €0 | - | - | - | - |
| Deferred taxes168 | €0.5m | €0.5m | €0.06m | €0.3m | €0.3m | ▼ 3.7% |
| Amounts payable17/49 | €52.8m | €99.2m | €91.0m | €82.0m | €76.7m | ▼ 6.5% |
| Amounts payable after more than one year17 | €5.5m | €7.7m | €70.5m | €55.9m | €61.1m | ▲ 9.2% |
| Financial debts170/4 | €5.5m | €7.7m | €20.6m | €8.4m | €19.0m | ▲ 126% |
| Other amounts payable178/9 | - | - | €50.0m | €47.5m | €42.0m | ▼ 11.5% |
| Amounts payable within one year42/48 | €47.3m | €91.5m | €20.5m | €26.1m | €15.6m | ▼ 40.1% |
| Current portion of amounts payable after more than one year42 | €0.6m | €0.6m | €0.8m | €7.1m | €1.0m | ▼ 86.4% |
| Financial debts43 | €3.5m | €5.0m | €1.8m | €5.9m | €13.4m | ▲ 127% |
| Credit institutions430/8 | €3.5m | €5.0m | €1.8m | €5.9m | €13.4m | ▲ 127% |
| Trade debts44 | €2.3m | €0 | €0.6m | €1.7m | €0.7m | ▼ 60.0% |
| Suppliers440/4 | €2.3m | €0 | €0.6m | €1.7m | €0.7m | ▼ 60.0% |
| Advances received on contracts in progress46 | - | €15.1m | €0 | - | - | - |
| Taxes, remuneration and social security45 | €0.7m | €0.7m | €0 | €0.1m | €0.6m | ▲ 340% |
| Taxes450/3 | €0.7m | €0.7m | €0 | €0.1m | €0.6m | ▲ 340% |
| Other amounts payable47/48 | €40.2m | €70.1m | €17.3m | €11.3m | €0.01m | ▼ 99.9% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €2.0m | -€4.8m | €6.2m | €0.7m | €2.4m | ▲ 232% |
| + Depreciation and write-downs630 | €0.4m | €0.4m | €0.4m | €0.4m | €0.3m | ▼ 21.7% |
| Operating cash flow (approximation) | €2.3m | -€4.4m | €6.6m | €1.1m | €2.7m | ▲ 146% |
| Investment in fixed assets (approximation) | - | -€35.1m | -€3.1m | €0.7m | €15.3m | ▲ 2,239% |
| Change in cash | - | €3.7m | -€8.2m | -€0.7m | €0.7m | ▲ 206% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Comparable companies
Similar companies · same sector, comparable size
Board & ownership
12 holdingsAuditor Mercken Bedrijfsrevisoren BV
Directors
Statutory auditor 1
Mandate history
- Statutory auditor
| Name | Functions and periods |
|---|---|
| Mercken Bedrijfsrevisoren BV |
|
Structure & network
Owners and holdings
12 holdings · 11 subsidiaries in the treeOwners 0
The accounts to 31-12-2025 list no shareholders, and no other source names one.
Holdings 12
-
100%
-
100%
-
100%
-
100%
-
100%
-
100%
-
97.82%
-
70%
-
50%
-
50%
Show 2 more holdings
- Sourceown accounts 202545%
-
33.33%
All subsidiaries, including indirect ones 11
Companies in which this company or one of its subsidiaries holds more than half, or which it consolidates according to the LEI register.
- G.I.V.O. 100%
- PROUDMOORE 100%
- RUMCO 100%
- SERBATOIO 100%
- TSB 100%
TSN 97.82%1 subsidiary
- ONE+ Residential 100%
- One+ city 70%
According to the 2025 annual accounts of TS 33 and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No directors read yet: 1 of 10 Gazette acts processed.
Capital and shareholders
- Cresens €5,000,000 in kind
- De Keyzer €5,000,000 in kind
The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.
Timeline
19 eventsLatest 27-07-2026Next filing 31-07-2027
History
Acts, filings and financial milestones
03-07
State Gazette act
Appointment: Mercken Bedrijfsrevisoren BV (statutory auditor)Auditor report · Declaration · Capital contribution11 facts ▸
- General meeting, 29-06-2026
- Auditor appointment, Mercken Bedrijfsrevisoren BV (statutory auditor)
- Auditor report, inbreng in natura, oordeel zonder voorbehoud
- Other statement, verslag bestuursorgaan over inbreng in natura, waarom inbreng van belang is voor de vennootschap
- Declaration, kennisname verslagen, aandeelhouders
- Other statement, neerlegging verslagen op griffie bevoegde Ondernemingsrechtbank, artikelen 2:8 en 2:14,4° Wetboek van vennootschappen en verenigingen
- Other statement, creatie nieuwe aandelen
- Capital contribution, €5.000.000
- Capital contribution, €5.000.000
- Power of attorney
- Other statement, bedrijfsrevisor,vertegenwoordiger, vertegenwoordiging commissaris
Show earlier events
About the unread acts
Of the 10 Belgian State Gazette acts we know for this company, 1 has been read. The other 9 have not been read yet: what they contain is neither established nor disproved here.
Support & recognitions
2 registers with recognitionsFASFC 1 siteLEI issued
Recognitions · licences · registrations
Food safety, FASFC
1 siteLegal Entity Identifier
Company details
Private limited company · founded 20-01-2015Year ends 31-12Peppol reachable1 site
Register details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 1 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Sites & property
1 establishment unit
1 parcel
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 72029C0124/00G000 | Flanders | 1,858 m² | 1 · 226 m² | 8.0 m · 2 fl. |
Linked by address, not proof of ownership
Go further with this company
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.